Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
4.28Price to Book
VS
Market
Sector
Industry
History
$ 2.97Close
$ 1.42 - $ 24.24 52-Week Range
Ticker Information
Ticker
XFORCompany Name
X4 PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQX4 PHARMACEUTICALS INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
XFOR - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 3.97M | $ 17M | 4.28 |
| 3/31/2025 | $ 22.94M | $ 21.71M | 0.95 |
| 12/31/2024 | $ 22.15M | $ 46.78M | 2.11 |
| 9/30/2024 | $ 59.62M | $ 47.29M | 0.79 |
| 6/30/2024 | $ 94.45M | $ 109.78M | 1.16 |
| 3/31/2024 | $ 1.04M | $ 183.05M | 176.69 |
| 12/31/2023 | $ 51.1M | $ 220M | 4.31 |
| 9/30/2023 | $ 67.59M | $ 132.16M | 1.96 |
| 6/30/2023 | $ 67.53M | $ 172.65M | 2.56 |
| 3/31/2023 | $ 51.68M | $ 188.2M | 3.64 |
Key Performance Insights, Last 5 Years
- X4 PHARMACEUTICALS INC's latest trailing twelve months (TTM) P/B stands at 1.09.
- Over the past 5 years, X4 PHARMACEUTICALS INC's average P/B has been 10.76.
- The median P/B for X4 PHARMACEUTICALS INC during this period was 1.9
- X4 PHARMACEUTICALS INC reached its highest P/B over the past 5 years at 176.69.
- The lowest P/B recorded by X4 PHARMACEUTICALS INC in the same timeframe 0.64
X4 PHARMACEUTICALS INC's P/B vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/B Benchmarks
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for X4 PHARMACEUTICALS INC is calculated as follows: Market Cap [ $ 97.88M ] / Equity [ $ 89.71M ]
(=) P/B [ 1.09 ] XFOR - Price to Book, Last 5 years
0.64
Minimum
Mar 31, 2022
176.69
Maximum
Mar 31, 2024
10.76
Average
1.9
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.29 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.29 |
| median | 1.63 |
| std | 1.81 |